Real-world effectiveness of original BNT162b2 mRNA COVID-19 against symptomatic Omicron infection among children 5-11 years of age in Brazil: A prospective test-negative design study.
Cristina de Oliveira RodriguesJulia SpinardiRegis Goulart RosaMaicon FalavignaEmanuel Maltempi de SouzaJosélia Larger ManfioAna Paula de SouzaCintia Laura Pereira de AraujoMírian CohenGynara Rezende Gonzalez do Valle BarbosaFernanda Kelly Romeiro SilvaDaniel SganzerlaMariana Motta Dias da SilvaDiogo FerreiraNicolas Taciano KunkelNathan Iori CamargoJean Carlos SarturiMárcia Cristina GuilhemJaqueline Carvalho de OliveiraCaroline Cardoso LopesFernanda WidmarLetícia Killes BarufiGabrielle Nunes da SilvaDaniela Fiori GradiaAna Paula Carneiro BrandalizeCarla Adriane RoyerRafael Messias LuizValter Antonio BauraHellen AbreuCarolina Gracia PoitevinGabriela Almeida KucharskiFernando PedrottiSrinivas Rao ValluriAmit SrivastavaViviane Wal JuliãoOlga Chameh MeloneKristen E AllenMoe H KyawGraciela Del Carmen Morales CastilloJohn M McLaughlinnull nullPublished in: Immunology letters (2024)
gov/ct2/show/NCT05403307).